Filing Details
- Accession Number:
- 0000899243-22-033167
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-10-06 16:59:27
- Reporting Period:
- 2022-10-04
- Accepted Time:
- 2022-10-06 16:59:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1805387 | Cerevel Therapeutics Holdings Inc. | CERE | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1830363 | John Renger | C/O Cerevel Therapeutics Holdings, Inc. 222 Jacobs Street, Suite 200 Cambridge MA 02141 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-10-04 | 10,018 | $3.50 | 12,722 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2022-10-04 | 14,982 | $10.28 | 27,704 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-10-04 | 25,000 | $30.00 | 2,704 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2022-10-04 | 10,018 | $0.00 | 10,018 | $3.50 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2022-10-04 | 14,982 | $0.00 | 14,982 | $10.28 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 70,128 | 2029-04-02 | No | 4 | M | Direct | |
| 119,933 | 2029-04-02 | No | 4 | M | Direct |
Footnotes
- These transactions were effected pursuant to a Rule 10b5-1 trading plan dated October 8, 2021 adopted by the Reporting Person.
- 25% of the shares subject to this option vested and became exercisable on April 8, 2020, with the remainder vesting in thirty-six (36) equal monthly installments thereafter.
Billionaire Hedge Funds
